Notice of Effectiveness (effect)
28 Marzo 2023 - 4:04AM
Edgar (US Regulatory)
|
UNITED STATES
|
|---|
|
SECURITIES AND EXCHANGE COMMISSION
|
|---|
|
Washington, D.C. 20549
|
|---|
NOTICE OF EFFECTIVENESS |
|---|
|
| Effective Date: | March 27,
2023 |
|---|
| Accession Number: | 0001493152-23-008806 |
|---|
| Submission Type: | POS AM |
|---|
| CIK: | 0001349929 |
|---|
| Company Name: | Vyant Bio, Inc. |
|---|
| File Number: | 333-218229 |
|---|
Cancer Genetics (NASDAQ:CGIX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Cancer Genetics (NASDAQ:CGIX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Cancer Genetics Inc (NASDAQ): 0 recent articles
Más de Vyant Bio, Inc. Artículos de Noticias